Other
Peanut
Peanut is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_1
1
25%
Ph phase_2
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function
NCT01405300
completedphase_2
Peanuts and Glycemic Control
NCT03654651
completednot_applicable
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population
NCT03194152
unknownnot_applicable
Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut
NCT02457416
Clinical Trials (4)
Showing 4 of 4 trials
NCT01405300Phase 1
The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function
NCT03654651Phase 2
Peanuts and Glycemic Control
NCT03194152Not Applicable
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population
NCT02457416Not Applicable
Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4